The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: -3.50 (-2.08%)
Spread: 10.00 (6.25%)
Open: 168.50
High: 168.50
Low: 162.00
Prev. Close: 168.50
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

4 Apr 2023 07:00

RNS Number : 2135V
Helios Underwriting Plc
04 April 2023
 

4th April 2023

 

 

Helios Underwriting plc

("Helios" or the "Company")

 

Directorship Change

 

Appointment of Martin Reith as Chief Executive

 

Helios, the unique investment vehicle that acquires and consolidates underwriting capacity at Lloyd's, is delighted to announce the appointment of Martin Reith as an Executive Director of the Company and as Chief Executive Officer ('CEO') with immediate effect. Nigel Hanbury will remain on the Board as Executive Deputy Chairman, so that the Board can continue to benefit from his leadership and his extensive knowledge of Lloyd's.

 

Martin Reith has nearly 40 years' experience across underwriting, management and leadership. Prior to joining Helios as a Non-Executive Director in 2021, he held board positions at Neon Underwriting Limited, as CEO from 2015 to 2019 and then assumed a non-executive role until 2020. For the last 12 months, Martin has been heavily involved in advising the Board on the curation of the Helios capacity portfolio.

 

Martin was the founder and CEO of Ascot Underwriting Limited, which he established in 2001 with the support and backing of AIG. Under his leadership, Ascot became one of the largest and top-performing businesses in Lloyd's with a network of overseas offices. In 2009, Martin stepped down as CEO and served as a non-executive on Ascot's board from 2009 to 2011. Prior to Ascot, he served as CEO of XL Capital's Insurance Operations in London. He is the founder of The Nick Kilhams Foundation, a suicide prevention charity focused on helping city professionals. He has also been a member of the board of directors at AmWINS Group Inc. and has previously served as a director to Securis Investment Partners LLP, an ILS fund based in London, on their various boards. He is currently non-executive chair at Artificial Labs and a board member of Prospero Re, the reinsurance vehicle of Bermuda headquartered ILS fund and investment manager Resolute Global Partners Ltd, a 17.3% shareholder of the Company.

 

Commenting on his appointment, Martin Reith said:

"Helios is an extraordinary business that has grown significantly in recent years and is seen as the benchmark for private capital in the Lloyd's market. I see exciting opportunities for further shareholder value creation, specifically by repositioning the earnings stream into a combination of underwriting returns, fees and commissions to support further profitable growth. I look forward to setting out my strategy in detail in due course."

 

 

Michael Cunningham, Non-Executive Chairman of Helios Underwriting, commented:

"We are delighted by Martin's elevation to CEO. His proven experience in driving growth strategies and creating significant shareholder value means that he is perfectly positioned to lead Helios on to its next stage of evolution.

 

"We are also very pleased that we will continue to benefit from Nigel's experience and expertise. In his decade as Chief Executive he has led Helios from strength to strength through strategically targeted acquisition activity and organic growth.

 

"With a plethora of opportunities open to us to take advantage of the current Lloyd's market conditions to drive further growth, we look to the future with confidence."

 

For further information please contact:

 

Helios Underwriting plc

Martin Reith - Chief Executive +44(0)7720 292 505

Nigel Hanbury - Executive Deputy Chairman +44 (0)7787 530 404

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7601 6100

David Coaten

 

Buchanan (PR)

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £297m of capacity for the 2023 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZGGDKFLGFZM
Date   Source Headline
28th Jun 20193:13 pmRNSResult of AGM
13th Jun 20197:00 amRNSChange of Adviser
13th Jun 20197:00 amRNSFundraising, Acquisition, Waiver & Notice of GM
31st May 20197:00 amRNSFinal results for the year ended 31 December 2018
30th May 20192:14 pmRNSDirector's Disclosure
17th May 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
10th May 20199:30 amRNSTrading Update
29th Mar 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20197:00 amRNSDirector Dealing
23rd Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20192:36 pmRNS2019 Capacity Update
9th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Dec 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20187:00 amRNSAcquisition of Lloyd's Member 54532L
6th Dec 201812:47 pmRNSCompletion of Acquisition
20th Nov 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
15th Nov 20187:00 amRNSAcquisition of Advantage DCP Limited
12th Nov 20187:00 amRNSHelios Capacity Fund
28th Sep 20187:00 amRNSHalf-year Report
26th Sep 20189:06 amRNSAcquisition of Nomina No 505 LLP
3rd Sep 201810:20 amRNSTotal Voting Rights
30th Aug 201811:17 amRNSAcquisition of Fyshe Underwriting LLP
20th Aug 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
20th Aug 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Aug 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20187:00 amRNSProposed acquisition of Fyshe Underwriting LLP
31st Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 20182:23 pmRNSResult of AGM
4th Jun 20185:16 pmRNSPosting of circular and notice of AGM
25th May 20187:00 amRNSFinal Results
22nd May 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
22nd Mar 20187:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Jan 20182:25 pmRNSHolding(s) in Company
14th Dec 20173:35 pmRNSDirector/PDMR Shareholding
12th Dec 201712:12 pmRNSReplacement - Holding(s) in Company
12th Dec 20179:30 amRNSHolding(s) in Company
12th Dec 20177:00 amRNSDirector's Dealing
8th Dec 20177:00 amRNSDirector Appointment
1st Dec 20178:52 amRNSDirector's Dealing
29th Nov 20177:00 amRNS2018 Capacity and Trading Statement
21st Nov 20177:00 amRNSQuarterly Syndicate Mid-point Forecasts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.